Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease

Coronaviruses cause diseases in humans and livestock. The SARS-CoV-2 is infecting millions of human beings, with high morbidity and mortality worldwide. The main protease (M<sup>pro</sup>) of coronavirus plays a pivotal role in viral replication and transcription, which, in theory, is an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuxi Lin, Ruochen Zang, Yanlong Ma, Zhuoya Wang, Li Li, Siyuan Ding, Rong Zhang, Zhiqiang Wei, Jinbo Yang, Xin Wang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/da701b4e744d46c897ce86e4a6d134bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da701b4e744d46c897ce86e4a6d134bb
record_format dspace
spelling oai:doaj.org-article:da701b4e744d46c897ce86e4a6d134bb2021-11-25T17:53:41ZXanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease10.3390/ijms2222121341422-00671661-6596https://doaj.org/article/da701b4e744d46c897ce86e4a6d134bb2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12134https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Coronaviruses cause diseases in humans and livestock. The SARS-CoV-2 is infecting millions of human beings, with high morbidity and mortality worldwide. The main protease (M<sup>pro</sup>) of coronavirus plays a pivotal role in viral replication and transcription, which, in theory, is an attractive drug target for antiviral drug development. It has been extensively discussed whether Xanthohumol is able to help COVID-19 patients. Here, we report that Xanthohumol, a small molecule in clinical trials from hops (<i>Humulus lupulus</i>), was a potent pan-inhibitor for various coronaviruses by targeting M<sup>pro</sup>, for example, betacoronavirus SARS-CoV-2 (IC<sub>50</sub> value of 1.53 μM), and alphacoronavirus PEDV (IC<sub>50</sub> value of 7.51 μM). Xanthohumol inhibited M<sup>pro</sup> activities in the enzymatical assays, while pretreatment with Xanthohumol restricted the SARS-CoV-2 and PEDV replication in Vero-E6 cells. Therefore, Xanthohumol is a potent pan-inhibitor of coronaviruses and an excellent lead compound for further drug development.Yuxi LinRuochen ZangYanlong MaZhuoya WangLi LiSiyuan DingRong ZhangZhiqiang WeiJinbo YangXin WangMDPI AGarticleXanthohumolnatural productSARS-CoV-2PEDVcoronavirusBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12134, p 12134 (2021)
institution DOAJ
collection DOAJ
language EN
topic Xanthohumol
natural product
SARS-CoV-2
PEDV
coronavirus
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle Xanthohumol
natural product
SARS-CoV-2
PEDV
coronavirus
Biology (General)
QH301-705.5
Chemistry
QD1-999
Yuxi Lin
Ruochen Zang
Yanlong Ma
Zhuoya Wang
Li Li
Siyuan Ding
Rong Zhang
Zhiqiang Wei
Jinbo Yang
Xin Wang
Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
description Coronaviruses cause diseases in humans and livestock. The SARS-CoV-2 is infecting millions of human beings, with high morbidity and mortality worldwide. The main protease (M<sup>pro</sup>) of coronavirus plays a pivotal role in viral replication and transcription, which, in theory, is an attractive drug target for antiviral drug development. It has been extensively discussed whether Xanthohumol is able to help COVID-19 patients. Here, we report that Xanthohumol, a small molecule in clinical trials from hops (<i>Humulus lupulus</i>), was a potent pan-inhibitor for various coronaviruses by targeting M<sup>pro</sup>, for example, betacoronavirus SARS-CoV-2 (IC<sub>50</sub> value of 1.53 μM), and alphacoronavirus PEDV (IC<sub>50</sub> value of 7.51 μM). Xanthohumol inhibited M<sup>pro</sup> activities in the enzymatical assays, while pretreatment with Xanthohumol restricted the SARS-CoV-2 and PEDV replication in Vero-E6 cells. Therefore, Xanthohumol is a potent pan-inhibitor of coronaviruses and an excellent lead compound for further drug development.
format article
author Yuxi Lin
Ruochen Zang
Yanlong Ma
Zhuoya Wang
Li Li
Siyuan Ding
Rong Zhang
Zhiqiang Wei
Jinbo Yang
Xin Wang
author_facet Yuxi Lin
Ruochen Zang
Yanlong Ma
Zhuoya Wang
Li Li
Siyuan Ding
Rong Zhang
Zhiqiang Wei
Jinbo Yang
Xin Wang
author_sort Yuxi Lin
title Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
title_short Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
title_full Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
title_fullStr Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
title_full_unstemmed Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
title_sort xanthohumol is a potent pan-inhibitor of coronaviruses targeting main protease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/da701b4e744d46c897ce86e4a6d134bb
work_keys_str_mv AT yuxilin xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT ruochenzang xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT yanlongma xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT zhuoyawang xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT lili xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT siyuanding xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT rongzhang xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT zhiqiangwei xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT jinboyang xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
AT xinwang xanthohumolisapotentpaninhibitorofcoronavirusestargetingmainprotease
_version_ 1718411891990069248